Companies: 49,247 Total Market Cap: 132646231814403.80

Ildong Holdings

KRX-000230
Healthcare Drug Manufacturers - Specialty & Generic
Rank #29392
Market Cap 48.67 M
Volume 18,035
Price 4.37
Change (%) 0.33%
Country or region South Korea South Korea

Ildong Holdings's latest marketcap:

48.67 M

As of 05/21/2025, Ildong Holdings's market capitalization has reached $48.67 M. According to our data, Ildong Holdings is the 29392th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 48.67 M
Revenue (ttm) 470.82 M
Net Income (ttm) 45.14 M
Shares Out 11.29 M
EPS (ttm) 3.63
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/21/2025

Ildong Holdings's yearly market capitalization.

Ildong Holdings has seen its market value drop from ₩156.40 B to ₩67.98 B since 2020, representing a total decrease of 56.53% and an annual compound decline rate (CAGR) of 17.29%.
Date Market Cap Change (%)
05/21/2025 ₩67.98 B -26.54%
12/30/2024 ₩91.92 B -22.62%
12/28/2023 ₩118.79 B -47.79%
12/29/2022 ₩227.54 B 36.15%
12/30/2021 ₩167.12 B 6.86%
12/30/2020 ₩156.40 B

Company Profile

Company Overview

Ildong Holdings Co., Ltd. is a South Korean pharmaceutical company engaged in the development, manufacturing, and supply of healthcare products. Founded in 1941 and headquartered in Seoul, the company operates both domestically and internationally.

Core Business Activities

  • Pharmaceutical Development: Focuses on new drugs targeting resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing.
  • Health Supplements: Produces raw vitamins, probiotics (including Biovita lactobacillus), and multivitamin products like Aronamin.
  • Health Foods & Ingredients: Researches and manufactures health foods, including hyaluronic acid for drugs, medical devices, and cosmetics.
  • Medical Distribution: Supplies medical devices, quasi-drugs, health supplements, food, beverages, and cosmetics via online platforms.
  • Prescription Drugs: Manufactures both original and generic prescription medications.

Additional Services

  • Probiotics production and distribution.
  • Pharmaceutical SI consulting, system development, RFID/barcode solutions.
  • Advertising and marketing services.

Corporate History

Formerly known as Ildong Pharmaceutical Co., Ltd., the company rebranded to Ildong Holdings Co., Ltd. in August 2016.

Frequently Asked Questions

As of 05/21/2025, Ildong Holdings (including the parent company, if applicable) has an estimated market capitalization of $48.67 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Ildong Holdings global market capitalization ranking is approximately 29392 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 1941
IPO Date n/a
Employees 80
CEO Dae-Chang Park
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address 2, Baumoe-ro 27-gil
Seoul, 06752
South Korea
Website https://www.ildongholdings.co.kr
People Also Watch
Zoetis
163.65 0.33%
Merck KGaA
132.41 0.33%
Haleon plc
548.39 0.33%
NSE-SUNPHARMA
19.96 0.33%